ANIDULAFUNGIN Gx anidulafungin 100 mg powder for injection vial

Pays: Australie

Langue: anglais

Source: Department of Health (Therapeutic Goods Administration)

Ingrédients actifs:

anidulafungin, Quantity: 100 mg

Disponible depuis:

Medis Pharma Pty Ltd

forme pharmaceutique:

Injection, powder for

Composition:

Excipient Ingredients: sucrose; polysorbate 80; tartaric acid

Mode d'administration:

Intravenous Infusion

Unités en paquet:

1 vial

Type d'ordonnance:

(S4) Prescription Only Medicine

indications thérapeutiques:

Treatment of invasive candidiasis, including candidaemia in adult and in paediatric patients one month and older (see Section 5.1 Pharmacodynamic Properties).

Descriptif du produit:

Visual Identification: White to off white powder, free of visible evidence of contamination; Container Type: Vial; Container Material: Glass Type I Clear; Container Life Time: 36 Months; Container Temperature: Store at 2 to 8 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Statut de autorisation:

Registered

Date de l'autorisation:

2022-03-11